In order to perform in vivo validation, we deciphered the miRNA complement of the Brca2/p53 −/− mammary tumor model (Brca2/p53 double knockout murine model) [19] using TLDA (mouse arrays), identifying shared miRNAs between both species. Here, TP53 is linked to breast cancer.